home.social

#prometheusbiosciences — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #prometheusbiosciences, aggregated by home.social.

fetched live
  1. #Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off #capitalism

  2. #Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off #capitalism

  3. gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, companies have tallied $64 billion in and deals this year. In the last few weeks alone, said it will pay $43 billion for , agreed to acquire for $10.8 billion, and said it will buy for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off

  4. #Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off #capitalism

  5. #Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off #capitalism